MDMA: historical perspectives.
Gibb
J W
JW
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City 84112.
Johnson
M
M
Stone
D
D
Hanson
G R
GR
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D015198:Designer Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D014365:Tryptophan Hydroxylase / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D015198:Designer Drugs; D015104:3,4-Methylenedioxyamphetamine; D014446:Tyrosine 3-Monooxygenase; D014365:Tryptophan Hydroxylase; D018817:N-Methyl-3,4-methylenedioxyamphetamine